{"pageContent": "Objectives: Erectile dysfunction (ED) is known to be a common consequence of radical treatment for prostate cancer (PCa) but is often under-reported and undertreated. This study aimed to explore how ED in patients with PCa is managed in real-life clinical practice, from the perspective of patients and healthcare professionals (HCPs).", "metaData": {"source": "The pre-treatment prevalence and types of sexual dysfunction among patients diagnosed with prostate cancer\nhttps://pubmed.ncbi.nlm.nih.gov/24127273/"}}